PTX3 and nephrocalcinosis: In summary, the opsonin and immune regulator PTX3 also modulates CaOx crystal aggregation and adhesion to tubular cell membranes and is therefore one of several endogenous inhibitors of stone formation in nephrocalcinosis and potentially in urolithiasis or other crystallopathies.